PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
J Comp Neurol. Author manuscript; available in PMC Mar 18, 2012.
Published in final edited form as:
PMCID: PMC3306808
NIHMSID: NIHMS356368
Genetic Tracing of Nav1.8-Expressing Vagal Afferents in the Mouse
Laurent Gautron,1* Ichiro Sakata,1 Swalpa Udit,1 Jeffrey M. Zigman,1 John N. Wood,2 and Joel K. Elmquist2
1Division of Hypothalamic Research, Departments of Internal Medicine and Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390
2Wolfson Institute for Biomedical Research, University College London, London WC1E 6BT, United Kingdom
*CORRESPONDENCE TO: Laurent Gautron, Division of Hypothalamic Research, Departments of Internal Medicine and Pharmacology, The University of Texas Southwestern Medical Center, Dallas, TX 75390. laurent.gautron/at/utsouthwestern.edu
Nav1.8 is a tetrodotoxin-resistant sodium channel present in large subsets of peripheral sensory neurons, including both spinal and vagal afferents. In spinal afferents, Nav1.8 plays a key role in signaling different types of pain. Little is known, however, about the exact identity and role of Nav1.8-expressing vagal neurons. Here we generated mice with restricted expression of tdTomato fluorescent protein in all Nav1.8-expressing afferent neurons. As a result, intense fluorescence was visible in the cell bodies, central relays, and sensory endings of these neurons, revealing the full extent of their innervation sites in thoracic and abdominal viscera. For instance, vagal and spinal Nav1.8-expressing endings were seen clearly within the gastrointestinal mucosa and myenteric plexus, respectively. In the gastrointestinal muscle wall, labeled endings included a small subset of vagal tension receptors but not any stretch receptors. We also examined the detailed inner-vation of key metabolic tissues such as liver and pancreas and evaluated the anatomical relationship of Nav1.8-expressing vagal afferents with select enteroendocrine cells (i.e., ghrelin, glucagon, GLP-1). Specifically, our data revealed the presence of Nav1.8-expressing vagal afferents in several metabolic tissues and varying degrees of proximity between Nav1.8-expressing mucosal afferents and enteroendocrine cells, including apparent neuroendocrine apposition. In summary, this study demonstrates the power and versatility of the Cre-LoxP technology to trace identified visceral afferents, and our data suggest a previously unrecognized role for Nav1.8-expressing vagal neurons in gastrointestinal functions.
INDEXING TERMS: vagotomy, autonomic nervous system, transgenic, visceral pain, obesity, connections
The vagus nerve is the longest of the cranial nerves, innervating most organs of the thoracic and the abdominal cavities, including the entire alimentary canal (Altschuler et al., 1989; Berthoud et al., 1990; Fox et al., 2000; Rinaman and Schwartz, 2004; Wang and Powley, 2000). It is a mixed nerve, with two-thirds of the fibers carrying afferent sensory information from the periphery to the central nervous system (CNS) and one-third carrying efferent motor information from the CNS to the periphery (Prechtl and Powley, 1990). Afferent cell bodies of the vagus nerve reside in the nodose ganglion (NG) and terminate in discrete termination fields of the nucleus of the solitary tract (NTS; Altschuler et al., 1989). Without question, vagal afferents play an important role in regulating postprandial functions. For instance, afferent fibers supplying the duodenum are sensitive to cholecystokinin (CCK), an endogenous peptide released by certain duode nal enteroendocrine cells during meals (Liddle, 1995). CCK acts by a paracrine mode of action on vagal mucosal afferents through the CCK-A-receptor subtype (Broberger et al., 2001; Patterson et al., 2002), resulting in meal termination and reduction of meal size (Gibbs et al., 1976; Moran et al., 1992). Many other enteroendocrine cell types exist, including ghrelin, glucagon-like peptide 1(GLP-1), and glucagon cells (Date et al., 2000; Drucker, 2001; Roth et al., 1990); however, their functional and anatomical interactions with visceral afferents have not been well delineated. In fact, the anatomical and physiological study of the afferent innervation of the viscera remains inherently challenging (Fox, 2006). One of the main reasons for this is the current lack of specifying molecular markers that could be used to identify and label vagal and spinal sensory endings in innervated tissues. Prior studies using tracer injections in the NG have been essential to our current understanding of the basic anatomy of vagal afferents (Berthoud et al., 1990; Fox et al., 2000; Powley et al., 2011; Wang and Powley, 2000). However, these injections inherently produce variable results and can be performed only unilaterally in rats (with even more difficulties in mice). In addition, these types of experiments are not compatible with long-term physiological experiments given the relative short life of conventional neural tracers. Hence, there are still important gaps in our knowledge of the impact of various physiological and pathophysiological conditions, including metabolic diseases on the afferent innervation of the viscera, as well as the anatomical interactions between these afferents and enteroendocrine cells.
Nav1.8 is a tetrodotoxin-resistant, sodium voltage-gated sodium channel essential for certain pain pheno-types to be elicited, including visceral pain (Akopian et al., 1999; Laird et al., 2002; Zimmermann et al., 2007). Specifically, Nav1.8 is required for acute noxious chemical stimuli (i.e., capsaicin) rather than lasting chemical stimuli or acute mechanical noxious stimuli. Originally, Nav1.8 was cloned from the dorsal root ganglion (DRG; Akopian et al., 1996) and later was found to be restricted to DRG nociceptors and a small number of low-threshold mechanoreceptors (Djouhri et al., 2003). The electrophysiological properties and anatomical features of DRG Nav1.8-expressing neurons have been extensively studied (Djouhri et al., 2003; Rush et al., 2006). Strikingly, Nav1.8 is also present in over 75% of sensory afferent cell bodies of the NG (Stirling et al., 2005), but the identity and role of vagal Nav1.8-expressing neurons remain undetermined. With the ultimate goal of better understanding this specific population of vagal neurons, this study was designed to characterize the projections and terminal fields of Nav1.8-expressing vagal neurons within viscera. To overcome the previously mentioned difficulties in labeling visceral afferents, we proposed to use mice that express the Cre recombinase under control of the Nav1.8 promoter to induce tdTomato fluorescent protein in Nav1.8-expressing afferents. Nav1.8-Cre-tdTomato mice allowed us to label Nav1.8-expressing vagal afferents and their endings in visceral tissues, with a particular emphasis on the gastrointestinal tract.
Transgenic mice
Transgenic mice expressing Cre recombinase under control of the Nav1.8 promoter were generated, and their initial characterization demonstrated that these mice indeed expressed Cre recombinase eutopically within Nav1.8-expressing neurons (Stirling et al., 2005). Also, the initial characterization of the mice demonstrated that the introduction of the Cre recombinase was seemingly without ill effect on the physiology of the Nav1.8-expressing neurons, because mice carrying one Nav1.8-Cre allele show normal pain behavior, and their DRG neurons have normal electrophysiological properties (Stirling et al., 2005). Nav1.8-Cre mice on a C57Bl/6 genetic background were maintained in our laboratory and genotyped using the following primers: 5′-ttacccggtgtgtgctgtagaaag-3′ (mSNSseq12a), 5′- tgtagatggactgcagaggatgga-3′ (mSNSseq13s), and 5′-aaatgttgctggatatagtttttactgcc-3′ (Cre-seq5a). The products of the wild-type allele and the Cre allele were detected by using 12a/13a and 13a/5a, respectively. Interestingly, embryonic and adult Cre recombinase expression reported by β-galactosidase activity shows a specific expression in small-diameter neurons in the DRG and trigeminal ganglion (TG) and many neurons in the NG (Stirling et al., 2005). β-Galactosidase activity in these neurons is visible from embryonic day E15, and no positive staining was observed in the brain, spinal cord, or peripheral tissues. Nav1.8-Cre mice were crossed with tdTomato reporter mice from the Jackson Laboratory (stock No. 007905); these mice possess a loxP-flanked Stop cassette preventing the expression of CAG-driven tdTomato expression. In Cre-expressing neurons, however, the transcriptional termination sequence is excised, allowing tdTomato production (Madisen et al., 2010). The excitation and emission maxima of tdTomato occur at 554 nm and 581 nm, respectively. Mice homozygous for the tdTomato gene were obtained on a B6-129S6 mixed background and genotyped according to the Jackson Laboratory's instructions. All the mice used in our study were males carrying one Nav1.8-Cre allele and one loxP-Stop-loxP-tdTomato allele (Nav1.8-Cre-tdTomato). Mice were housed in a light-controlled (12 hours on/12 hours off; lights on at 7:00 Am) and temperature-controlled (21.5-22.5 ° C) environment. The animals and procedures used were approved by the University of Texas Southwestern Medical Center at Dallas Institutional Animal Care and Use Committees.
Histology
On the day of sacrifice, at about 9 am, mice were deeply anesthetized with chloral hydrate (500 mg/kg, i.p.) and transcardially perfused with 10% formalin. Tissues of interest were collected with a dissecting scope. The tdTomato protein native fluorescence was directly visualized in whole mounts or in cryostat-cut sections (14–16 μm) collected on SuperFrost slides after an overnight incubation in 20% sucrose. Some of our samples were labeled to detect calcitonin gene-related peptide (CGRP), ghrelin, glucagon-like peptide 1 (GLP-1), and glucagon. Sections were incubated overnight in the primary antiserum against CGRP (Bachem/Peninsula Laboratories, Campbell, CA), ghrelin (Phoenix Pharmaceutical), GLP-1 (Bachem/Peninsula Laboratories), or glucagon (Milli-pore/Linco, Bedford, MA) in 3% normal donkey serum with 0.25% Triton X-100 in PBS (PBT; pH7.4; Table 1). After several washes, sections were incubated in anti-rabbit AlexaFluor 488-conjugated (Invitrogen, Carlsbad, CA; catalog No. A11008; 1:1,000) or AlexaFluor 350-conjugated (Invitrogen, catalog No. A10039; 1:1,000) secondary antibody for 1 hour at room temperature. All our samples were coverslipped with Vectashield mounting medium with DAPI (Vector, Burlingame, CA; H-1500). Eight Nav1.8-Cre-tdTomato mice (~6 weeks of age) were used for our mapping experiments. Labeling of CGRP and enteroendocrine hormones was performed in three additional mice.
TABLE 1
TABLE 1
Primary Antisera
Antibodies
The rabbit polyclonal antiserum against calcitonin gene-related peptide (CGRP; Bachem, previously Peninsula Laboratories) is listed in the Journal of Comparative Neurology database and was previously used by us to label the innervation of the mouse myenteric plexus (Gautron et al., 2010), mouse esophageal myenteric ganglion (Kraus et al., 2007), fibers in the lamb intestine (Chiocchetti et al., 2006), and neurons in the mouse trigeminal ganglion (Kosaras et al., 2009). The antiserum recognizes canine, rat, and mouse α-CGRP as determined by radioimmunoassay (Peninsula data sheet). It also detects a single band of 4 kDa on Western blots of mouse trigeminal ganglion, and preadsorption with α-CGRP eliminated this band (Kosaras et al., 2009). Similarly, preadsorption using CGRP completely prevented the immunostaining in the lamb intestine (Chiocchetti et al., 2006) and the mouse trigeminal ganglion (Kosaras et al., 2009). The staining obtained in the present study was in agreement with the known distribution of CGRP in fibers terminating in the myenteric plexus (Phillips and Powley, 2007).
The rabbit polyclonal antiserum against glucagon (Milli-pore, previously Linco) recognizes a mixture of porcine and bovine glucagon (Halpern et al., 1984). Notably, glucagon is conserved in almost all mammals. This antibody has been widely used over the last decades to stain glucagon-producing cells in the mouse pancreas (Esni et al., 1999; Fujitani et al., 2006; Heiser et al., 2006). Based on their shape, number, and distribution within the mouse pancreatic islets, glucagon cells cannot be confounded with insulin-containing β-cells or exocrine cells. The antiserum used in these studies and our work labeled cells uniquely localized at the islets periphery that did not contain insulin (Esni et al., 1999; Fujitani et al., 2006; Heiser et al., 2006). Omission of the primary antibody eliminated all staining (not shown). Furthermore, this antibody produces no staining in glucagon cell-deficient mice (Hancock et al., 2010), confirming its specificity.
The rabbit polyclonal antiserum against glucagon-like peptide 1 (GLP-1; Bachem) recognizes the amidated C-terminus of GLP-1(7-36) of most mammalian species and shows limited cross-reactivity with the unamidated forms of GLP-1 and other related peptides such as GLP-2, glucagon, hGIP, and VIP (manufacturer's data). One study by Theodorakis et al. (2006) characterized this antiserum in human duodenal samples using preadsorption tests with GLP-1 and substitution of primary antiserum. Further validation was obtained by performing double labeling using this antiserum in combination with two other mouse monoclonal antibodies against GLP-1 (1-36; Statens Serum Institut, Copenhagen, Denmark) and (7–36) amide (Immundiagnostik Germany). All three antibodies labeled the same cells. Finally, the labeling obtained in our study matched the known shape and distribution of GLP-1 cells in the mouse intestinal cells with this antiserum (Edfalk et al., 2008; Nikoulina et al., 2010).
The goat polyclonal antiserum against ghrelin (Phoenix Pharmaceutical) was characterized using preadsorption tests with 50 μg/ml murine acylated ghrelin (catalog No. C-et-004; Global Peptide, Fort Collins, CO; suspended in saline) in 7,339 pancreatic cell lines. Omission of the primary antibody and preadsorption eliminated all staining (not shown). On immunoblots of rat stomach homogenates, the antibody detected a band at 13.7 kDa corresponding to pre-proghrelin (manufacturer's data). In addition, this antibody was used to label ghrelin cells in the stomach of ghrelin-hrGFP mice (Sakata et al., 2009a). Ghrelin immunoreactivity was visualized only in ghrelinhrGFP cells, demonstrating its specificity. Dual-label histochemical studies also revealed that this antibody stained ghrelin O-acyltransferase-expressing cells in the mouse stomach (Sakata et al., 2009b). The pattern of staining in the present study revealed ghrelin immunore-activity restricted to glandular cells in the gastric mucosa as previously reported (Sakata et al., 2009a,b).
Subdiaphragmatic bilateral vagotomies
Mice were anesthetized with a mixture of ketamine Hcl and xylazine HCl (80/12 mg/kg, i.p.) and then laparotomized on the left side of the abdomen. With a dissecting scope, the left and right vagi were isolated from the esophagus just below the diaphragm and cut with fine scissors. Animals were killed 4 days following the nerve cut, and their tissues were collected after perfusion. In total three Nav1.8-Cre-tdTomato were vagotomized.
Microscopy and image analysis
Images were captured with a Zeiss microscope (Imager ZI) equipped with a scanning stage and attached to the ApoTome system and a digital camera (Axiocam MRm). Briefly, the Apotome module was applied to produce confocal-like images, and the MosaiX module allowed us to scan automatically large specimens in the X-, Y-, and Z-axes. In some instances, the 4D module of Axiovision 4.5 was also used to reconstruct specialized endings in three dimensions. Axiovision 4.5 was also used to stitch digital images together and to perform measurements.
We estimated the proportion of tdTomato- and CGRP-positive neurons in sensory ganglia in 16-μm sections collected from three mice (×20 magnification). Data are presented as the percentage of tdTomato- and/or CGRP-positive neurons relative to the total number of counted neurons identified by DAPI counterstaining. In addition, the density of intraganglionic laminar endings (IGLEs) was determined in the muscle layers of the duodenum (2 cm below the pylorus) and prepared as sets of whole mounts by separation of the mucosal layer before being flattened on gelatin-coated slides. IGLEs were manually counted (×20 magnification) in the entire surface of the duodenal wall (~2 cm × 0.8 cm). No correction factors were applied to our measurements because they were performed in whole mounts. The counting and morphological criteria used to identify specialized vagal sensory endings are based on prior studies (Berthoud and Neuhuber, 2000; Wang and Powley, 2000). Qualitative estimates of the anatomical proximity of enteroendocrine cells with visceral endings were performed considering the distance separating individual cells and the nearest visible afferents (×20 and verted ×40 magnification). Our results were con-into percentage of cells with apparent contacts, close proximity (<10 μm), and relative or no proximity (>10 μm or absence of nearby afferents). Analysis was manually performed on 14-μm sections labeled for each enteroendocrine hormone in a total of three mice.
Adobe Photoshop CS2 was used to combine drawings and digital images into plates. The contrast and brightness of images were adjusted when necessary. In addition, red-green fluorescence images were converted to magenta-green for color-blind readers.
Distribution of tdTomato in sensory ganglia and central relays
Nav1.8-Cre-tdTomato mice showed bright native fluorescence in neuronal cell bodies known to express Nav1.8 (Figs. 1, ,2).2). This included neurons in the NG and the attached jugular/petrosal ganglionic mass (Figs. 1A,C, ,2C),2C), the DRG (Figs. 1E,F, ,2D),2D), the TG (Figs. 1H,I, ,2A),2A), and the vestibular/geniculate ganglionic mass (Fig. 2B). A few neurons were also observed in the superior cervical ganglion (Fig. 3A). Although a majority of neurons was fluorescent in all examined sensory ganglia, tdTomato appeared to be absent in certain neurons. The largest number of tdTomato-positive neurons was found in the NG (~82%) and the smallest in the TG (~67%; Fig. 2G). By using immunohistochemistry, we further assessed the expression of CGRP in tdTomato-positive neurons (Fig. 2E,F). In agreement with the expectation that many Nav1.8-expressing neurons might contain CGRP (Abrahamsen et al., 2008), our estimates revealed that nearly all CGRP neurons coexpressed tdTomato in NG and DRG (Fig. 2G). tdTomato was not seen in cell bodies within the central nervous system or in peripheral tissues, indicating the specificity of its expression pattern. However, tdTomato was occasionally seen in a small number of isolated myenteric neurons in the muscle wall of the intestines (Fig. 3E).
Figure 1
Figure 1
A–I: Distribution of tdTomato fluorescence in sensory ganglia and central relays in the brainstem and spinal cord of Nav1.8-CretdTomato mice. Bright fluorescence was seen in whole mounts of the brainstem, including the NG (A,C) and its terminal (more ...)
Figure 2
Figure 2
Characterization of tdTomato-positive neurons in sensory ganglia of Nav1.8-Cre mice. A large proportion of neurons was fluorescent in sections of the TG (A), vestibular/geniculate complex (B), NG (C), and DRG (D; epifluorescence and ApoTome). CGRP immunostaining (more ...)
Figure 3
Figure 3
A–E: Additional description of tdTomato distribution in the vagus nerve and gut. Isolated neurons were seen in the SCG (whole mount; A) and the intestinal myenteric plexus (whole mount; D). The sensory component of the dorsovagal complex is heavily (more ...)
Two previously reported properties of the tdTomato protein were confirmed in the current study, including its strong native fluorescence and its axonal transport (Madisen et al., 2010; Muzumdar et al., 2007). As a result, tdTomato could be easily seen without the need for immunostaining in the cell bodies of afferent neurons as well as in their central relays within the brainstem and spinal cord. In particular, tdTomato fluorescent fibers originating from the NG were clearly seen ending within the nucleus of the solitary tract (NTS; Figs. 1A,B,D, ,3B),3B), the adjacent area postrema (Fig. 3B), and the vagus nerve itself (Fig. 3C). Likewise, fluorescence was observed in the spinal trigeminal nucleus (sp5; Fig. 1B,D), which receives innervation originating from the TG (Fig. 1H,I). In the spinal cord, fibers were observed terminating in the dorsal horn (Fig. 1G).
Anatomical mapping of tdTomato-containing peripheral axons and terminals
Nav1.8-Cre-tdTomato mice showed robust fluorescence in afferent fibers and terminals throughout tissues innervated by Nav1.8-expressing vagal and spinal neurons, thus revealing the full extent of their innervation sites (Fig. 4). In addition, tdTomato-containing fibers were seen traveling in tissues known to be inner-vated by TG and geniculate ganglion neurons such as the meninges (Fig. 4A) and the gustatory papillae (Fig. 4B), respectively. A more detailed description of the innervation of the tongue is also provided (Fig. 5), which reveals the innervation of the taste buds. Organs innervated by both vagal and spinal sensory neurons contained tdTomato fibers, including lungs (Fig. 4D), alimentary canal (Fig. 4C), and islets of Langherans in the pancreas (Fig. 4E). As anticipated, the bladder and skin were also heavily innervated by spinal Nav1.8-expressing neurons (Fig. 4G,I). The white adipose tissue contained blood vessels frequently associated with fluorescent fibers (Fig. 4H). Immune tissues were completely devoid of innervation (i.e. thymus, Peyer's patches, spleen), with the exception of the lymph nodes, which displayed innervation localized around blood vessels (Fig. 4F). All other examined tissues, including the heart, kidneys, and adrenals, exhibited innervation associated with large blood vessels (not shown).
Figure 4
Figure 4
Examples of fluorescent fibers and terminals within selected tissues in Nav1.8-Cre-tdTomato mice. Bright native fluorescence (epifluorescence and ApoTome) was visible in various tissues innervated by sensory neurons, including the meninges (flattened (more ...)
Figure 5
Figure 5
Reconstruction of the tongue innervation in Nav1.8-Cre-tdTomato mice. With the MosaiX module (Zeiss), we reconstructed the innervation of the tongue on a 16-μm cryostat-cut section (4×4 stitched tiles, five optical sections, 1-μm (more ...)
Several studies have suggested that the hepatic branch of the vagus nerve exerts important regulatory actions on hepatic glucose fluxes (Cardin et al., 2002; Lam et al., 2010; Pocai et al., 2005). However, the inner-vation of the liver and gallbladder has rarely been described in mice. In Nav1.8-Cre-tdTomato mice, the wall of the gallbladder was richly innervated by bundles of fibers running along the main axis of blood vessels and in peri- and paravascular plexuses interconnected by perpendicular bridges (Fig. 6A). At the level of the hepatic hilum, varicose axons and terminals were consistently seen running in the adventia of the bile ducts and hepatic artery and in the wall of the portal vein (Fig. 6E,F). Hepatic triads of varied diameters also displayed innervation (Fig. 6D), sometimes deep into the liver lobules, but hepatocytes themselves were never in apposition with neuronal fibers. The innervation of the liver and gallbladder was only partially reduced after vagotomy, indicating that it is made up of both spinal and vagal afferents (Fig. 6C).
Figure 6
Figure 6
Detailed innervation of the mouse gallbladder and liver. Abundant innervation was seen in paravascular plexuses in the muscle wall of the gallbladder (A, whole mount; B, cryostat-cut section). Interestingly, vagotomy only partially reduced the innervation (more ...)
Identifying vagal ending specializations
Vagal afferent ending specializations can be identified based on their morphological features and anatomical distribution (Powley et al., 2011). We examined whether our mouse model could be used to identify afferent endings of different types, with a particular emphasis on the gastrointestinal tract. Mucosal endings were found wandering within the stomach and the entire length of the intestines (Figs. 4C, ,7B).7B). For instance, these endings were seen in the duodenal villi and crypts, as well as in the antral gland (Figs. 4C, ,7B,7B, 8B,C). The muscular layers of the gastrointestinal tract receive innervation from two subcategories of specialized mechanoreceptors known as intraganglionic laminar endings (IGLEs) and intramuscular arrays (IMAs), which are thought to serve as tension and stretch receptors, respectively. IGLEs were clearly identified in the myenteric plexus of the duodenum and stomach (Fig. 7A). Typically, IGLEs formed leafy structures with terminal puncta overlying myenteric neurons (Fig. 7A,C). Using automated microscopy, we reconstructed the wall of the duodenum of Nav1.8-Cre-tdTomato mice and counted IGLEs. Interestingly, the density of duodenal IGLEs (0.6±0.08/mm2; n = 9) was lower than expected based on prior evaluations in mice and rats (~10/mm2; Berthoud et al., 1997; Fox et al., 2000), indicating that Nav1.8 is expressed in only a subgroup of IGLEs. By contrast, fibers resembling IMAs were not observed in the Nav1.8-Cre-tdTomato mice. Notably, all the aforementioned terminals including IGLEs and mucosal fibers were eliminated after bilateral subdiaphragmatic vagotomy, confirming their vagal origin (Fig. 3D). Nonetheless, vagotomized mice did show persistent tdTomato-positive terminals in the gastrointestinal tract, with morphological features different from those described above (Fig. 7E,F). Their survival following vagotomy suggests a spinal origin. These fibers were generally thin and highly varicose, encircled myenteric neurons in the stomach and duodenum (Fig. 7C′,E), and were often CGRP positive (Fig. 7F). For comparison with the gastrointestinal tract, we also examined the aortic arch and heart, which are innervated by two distinct types of vagal mechanoreceptors and chemoreceptors (Cheng et al., 1997a,b). The Nav1.8-Cre-tdTomato mice showed fluorescence in aortic bodies that contain chemoreceptors (Fig. 7D) and some degree of innervation around blood vessels of the heart (not shown), but mechanoreceptors in the aortic arterial wall and heart were not labeled.
Figure 7
Figure 7
Identified specialized endings in Nav1.8-Cre-tdTomato mice. In whole mounts of the duodenum, tdTomato-positive fibers (epifluorescence and Apotome) are observed terminating the myenteric plexus forming specialized endings known as intraganglionic laminar (more ...)
Figure 8
Figure 8
Anatomical proximity of Nav1.8-expressing mucosal afferents with select enteroendocrine cells. In the pancreas, tdTomato-positive fibers (epifluorescence and Apotome) are observed near glucagon-positive cells (AlexaFluor488; A). On occasion, varicose (more ...)
Anatomical interactions between mucosal afferents and enteroendocrine cells
To clarify the interaction of the nervous system with enteroendocrine cells, we sought to examine the anatomical proximity of mucosal afferents with ghrelin, glucagon and GLP-1-producing cells in the gut. We categorized enteroendocrine cells and mucosal afferents as showing either apparent contacts suggesting neuroendocrine interactions, close proximity (<10 μm from nearest afferents), or relative or no proximity (>10 μ or absence of nearby afferents). In the pancreas, glucagon-positive cells were encountered at the periphery of the islets of Langherans, frequently in close proximity to fluorescent fibers (24% of glucagon cells; Fig. 8A). Furthermore, a significant proportion of glucagon cells (21%) displayed apparent apposition with varicose fibers (Fig. 8A–A′′). For the stomach, we found many ghrelin cells in the gastric mucosa (Fig. 8C), soome of which were in the immediate vicinity of afferents (30% of ghrelin cells; Fig. 8C,C′). Notably, although no specialized endings could be readily identified, a small proportion of ghrelin cells (7%) appeared to display apparent apposition with nearby varicose afferents (Fig. 8C′). In the duodenum, GLP-1 cells harboring luminal processes were typically seen in crypts and villi (Fig. 8B). Afferents in the duodenum often approached GLP-1 cells but were rarely close enough to be within the immediate vicinity (only 6% of GLP-1 cells) or to make contacts (Fig. 8B). Collectively, our observations reveal varying degrees of anatomical proximity, including apparent neuroendocrine apposition, between vagal afferents and select enteroendocrine cells.
Gut-to-brain communication involves endocrine mechanisms as well as direct innervation by cranial and spinal nerves. In the present study, we examined the innervation of the viscera in mice with Nav1.8-dependent expression of tdTomato fluorescent protein, with a particular emphasis on the gastrointestinal tract. We demonstrated the usefulness of this reporter model to label vagal endings in mice and, furthermore, reassess the innervation of tissues poorly described in the past. Finally, we took advantage of this model to examine the anatomical proximity of select enteroendocrine cells with Nav1.8-expressing mucosal afferents.
Technical considerations
Even though immunohistochemistry can be useful in labeling neuropeptides or receptors found in certain vagal and spinal visceral endings (Green and Dockray, 1987; Lindsay et al., 2006; Mitsui, 2009; Patterson et al., 2002; Phillips and Powley, 2007; Wang and Neuhuber, 2003), study of the anatomical connections between visceral organs and the nervous system has been impeded by the neurochemical heterogeneity and complex branching of afferent neurons. In a prior study (Gautron et al., 2010), we used MC4R-GFP mice to label subsets of vagal afferents and efferents. Nevertheless, GFP was expressed in only a fraction of vagal neurons, and it was not bright enough to be seen without immunohistochemical amplification. The approach described here overcomes this problem by permitting the visualization of large subsets of peripheral sensory neurons and their terminals within innervated tissues. In essence, it allows the visualization of tdTomato only in neurons that express Nav1.8 and not in any other cells. In addition, the native fluorescence of tdTomato is bright enough to be seen without any histo-chemical processing. Remarkably, tdTomato is transported to axon terminals in central relays and sensory endings in multiple innervated organs. Finally, one major advantage of our approach is that it allows the reporter protein to be expressed invariably in sensory neurons regardless of Nav1.8 levels. This is an important point, in that Nav1.8 expression levels may vary dramatically under various physiological conditions (Strickland et al., 2008; Wang et al., 2006). Therefore, our genetic approach offers advantages over other techniques for labeling Nav1.8-expressing neurons, including Nav1.8 immunostaining.
This study shows that not all sensory fibers of vagal origin were equally represented in the Nav1.8-Cre-tdTomato mice. Specifically, Nav1.8-expressing vagal afferents were represented predominantly by mucosal endings in the stomach and intestines. These fibers are well-known multimodal afferents capable of responding to mechanical stroke and various chemical stimuli, including enter-oendocrine peptides (Iggo, 1957; Raybould, 2010). In addition, Nav1.8-expressing afferents were represented by a small subset of IGLEs, which are supposedly mechanoreceptors capable of detecting tension (Phillips and Powley, 2000), but not any IMAs and aortic baroreceptors. These results mirror well the previously described absence of Nav1.8 in spinal mechanoreceptors with the exception of a few low-threshold mechanoreceptors (Djouhri et al., 2003). It is also interesting to note that the proportion of Nav1.8-expressing neurons revealed by tdTomato fluorescence was more elevated than previously reported in both NG and DRG (Stirling et al., 2005). This may be due to the fact that the removal of the Stop cassette in this reporter line occurs in the presence of a very small amount of Cre, thus resulting in the labeling of neurons expressing low levels of Nav1.8.
Notably, the current reporter system is very sensitive, because the density of mucosal endings (seen in 16 μm sections of the duodenum) is relatively high, with at least 50% of the villi displaying visible innervation as opposed to only 10% using conventional anterograde tracing techniques (Berthoud and Patterson, 1996). One obvious application of our approach is the assessment of the completeness of vagotomies, which has been difficult in the past. For example, we showed that subdiaphragmatic vagotomy resulted in the complete loss of tdTomato-positive vagal sensory endings below the nerves cut, as opposed to CGRP-positive fibers of spinal origin, which seemed to be unaffected by vagotomy. Overall, it appears that Nav1.8-Cre-tdTomato mice are a useful model for visualizing and surveying vagal and spinal sensory networks innervating the gastrointestinal tract in the intact mouse. For instance, the current description of the inner-vation of the mouse liver and gallbladder is in good agreement with previous immunohistochemical and antero-grade studies performed in rats and guinea pigs (Berthoud et al., 1992; Mawe, 1998). We also showed that Nav1.8-Cre-tdTomato mice can be used to trace nociceptors innervating the skin and certain neurons in the facial and trigeminal nerves, which may be useful in many areas of research on taste, pain, and migraine.
Putative role of Nav1.8-expressing vagal afferents
As mentioned above, Nav1.8 plays a key role in signaling various types of pain (Akopian et al., 1999; Laird et al., 2002; Zimmermann et al., 2007). Because spinal nociceptors in the viscera have been well-described in the past (Cervero, 1994), the presence of Nav1.8-expressing afferents of spinal origin in the gastrointestinal tract is not a surprising finding. By contrast, the presence of Nav1.8-expressing vagal fibers is most intriguing, given that vagal afferents are thought to be concerned mostly with homeostatic stimuli but not noxious stimuli. Although anatomical and electrophysiological studies have reported the presence of Nav1.8 in vagal neurons (Matsumoto et al., 2007; Stirling et al., 2005), the functional relevance of TTX-resistant sodium channels in vagal afferents remains unknown. The intestinal mucosa, for instance, is richly innervated by Nav1.8-expressing vagal afferents even though this tissue is supposedly insensitive to pain (Cervero, 1994). One possible explanation is that Nav1.8 located in these particular vagal afferents may play a previously unrecognized role in modulating their activity in response to nonnociceptive stimuli, including enteroendocrine peptides (see below). If this hypothesis is verified in future studies using Nav1.8 knockout mice, this may suggest that Nav1.8 could be involved in homeostatic functions in addition to pain. Similarly, the innervation of taste buds and aortic chemoreceptors by Nav1.8-expressing neurons raises the question of a possible involvement of TTX-resistant sodium channels in taste sensing and cardiovascular functions, respectively.
Neuroenteroendocrine interactions
As mentioned above, one of the major functions of mucosal afferents is to detect enteroendocrine peptides locally released in response to meal ingestion (Raybould, 2010). For instance, vagal sensory neurons do express receptors for GLP-1 (Nakagawa et al., 2004; Vahl et al., 2007) and ghrelin (Burdyga et al., 2006; Sakata et al., 2003), which are supposedly trafficked to peripheral endings. In the case of ghrelin cells, several studies have shown that an intact vagus nerve is required for many of ghrelin physiological effects in mice and men (Date et al., 2002; Huda et al., 2010; le Roux et al., 2005). Our data give credit to the “vagal hypothesis” of ghrelin's action on physiological functions. This study shows close proximity and apparent neuroendocrine contacts between afferents and enteroendocrine cells, including glucagon cells and to a lesser extent ghrelin cells. By comparison, GLP-1 cells were not approached as closely by mucosal afferents, revealing varying degrees of anatomical proximity between visceral endings and different enteroendocrine cell types. To the best of our knowledge, this type of investigation has been previously conducted only with conventional tracers to examine the relationship of vagal afferents with intestinal CCK cells (Berthoud and Patterson, 1996) and nNOS cells (Page et al., 2009). The two latter studies revealed loose appositions between vagal neurons and CCK and nNOs cells, which is in agreement with our observations on GLP-1 cells. However, these studies did not examine other cell types or tissues. Together, our data suggest that mucosal endings can interact via both paracrine and neuroendocrine mechanisms with glucagon and ghrelin cells.
Perspectives
In summary, we describe how genetic tracing offers numerous advantages over conventional tracing and immunohistochemical approaches to label visceral endings. In the future, we hope that the approach can be useful in many areas of gut-to-brain research that require the visualization of visceral afferents and/or nociceptors, especially for scientists not familiar with conventional tracing techniques. For instance, diabetes is a known leading cause of injury to the peripheral nervous system (Drel et al., 2006; Obrosova et al., 2007). Thus, it would be interesting to examine the integrity of visceral afferents in diabetic animals. Also, visceral afferents display morphological remodeling in response to physical insults (Phillips and Powley, 2005; Powley et al., 2005). These observations suggest that the surgical reconstruction of the alimentary canal, which is currently one of the most frequently performed weight-loss surgeries, is likely to produce a reorganization of visceral networks as a result of both deafferentation and regeneration processes. Hence, it would particularly worthwhile investigating the innervation of the gastrointestinal tract in tdTomato reporter mice following weight-loss surgery in the mouse model described in this study.
Acknowledgments
Grant sponsor: National Institutes of Health; Grant number: PL1 DK081182; Grant number: UL1 RR024923; Grant number: NID DK088761-01 (to J.K.E); Grant number: R01 DK53301 (to J.K.E); Grant number: RL1 DK081185 (to J.K.E); Grant number: RO1 DA024680 (to J.M.Z.).
  • Abrahamsen B, Zhao J, Asante CO, Cendan CM, Marsh S, Martinez-Barbera JP, Nassar MA, Dickenson AH, Wood JN. The cell and molecular basis of mechanical, cold, and inflammatory pain. Science. 2008;321:702–705. [PubMed]
  • Akopian AN, Sivilotti L, Wood JN. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature. 1996;379:257–262. [PubMed]
  • Akopian AN, Souslova V, England S, Okuse K, Ogata N, Ure J, Smith A, Kerr BJ, McMahon SB, Boyce S, Hill R, Stanfa LC, Dickenson AH, Wood JN. The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci. 1999;2:541–548. [PubMed]
  • Altschuler SM, Bao XM, Bieger D, Hopkins DA, Miselis RR. Viscerotopic representation of the upper alimentary tract in the rat: sensory ganglia and nuclei of the solitary and spinal trigeminal tracts. J Comp Neurol. 1989;283:248–268. [PubMed]
  • Berthoud HR, Neuhuber WL. Functional and chemical anatomy of the afferent vagal system. Auton Neurosci. 2000;85:1–17. [PubMed]
  • Berthoud HR, Patterson LM. Anatomical relationship between vagal afferent fibers and CCK-immunoreactive entero-endocrine cells in the rat small intestinal mucosa. Acta Anat. 1996;156:123–131. [PubMed]
  • Berthoud HR, Jedrzejewska A, Powley TL. Simultaneous labeling of vagal innervation of the gut and afferent projections from the visceral forebrain with dil injected into the dorsal vagal complex in the rat. J Comp Neurol. 1990;301:65–79. [PubMed]
  • Berthoud HR, Kressel M, Neuhuber WL. An anterograde tracing study of the vagal innervation of rat liver, portal vein and biliary system. Anat Embryol. 1992;186:431–442. [PubMed]
  • Berthoud HR, Patterson LM, Neumann F, Neuhuber WL. Distribution and structure of vagal afferent intraganglionic laminar endings (IGLEs) in the rat gastrointestinal tract. Anat Embryol. 1997;195:183–191. [PubMed]
  • Broberger C, Holmberg K, Shi TJ, Dockray G, Hokfelt T. Expression and regulation of cholecystokinin and cholecystokinin receptors in rat nodose and dorsal root ganglia. Brain Res. 2001;903:128–140. [PubMed]
  • Burdyga G, Varro A, Dimaline R, Thompson DG, Dockray GJ. Ghrelin receptors in rat and human nodose ganglia: putative role in regulating CB-1 and MCH receptor abundance. Am J Physiol Gastrointest Liver Physiol. 2006;290:G1289–G1297. [PubMed]
  • Cardin S, Walmsley K, Neal DW, Williams PE, Cherrington AD. Involvement of the vagus nerves in the regulation of basal hepatic glucose production in conscious dogs. Am J Physiol Endocrinol Metab. 2002;283:E958–E964. [PubMed]
  • Cervero F. Sensory innervation of the viscera: peripheral basis of visceral pain. Physiol Rev. 1994;74:95–138. [PubMed]
  • Cheng Z, Powley TL, Schwaber JS, Doyle FJ., 3rd A laser confocal microscopic study of vagal afferent innervation of rat aortic arch: chemoreceptors as well as baroreceptors. J Auton Nerv Syst. 1997a;67:1–14. [PubMed]
  • Cheng Z, Powley TL, Schwaber JS, Doyle FJ., 3rd Vagal afferent innervation of the atria of the rat heart reconstructed with confocal microscopy. J Comp Neurol. 1997b;381:1–17. [PubMed]
  • Chiocchetti R, Grandis A, Bombardi C, Lucchi ML, Dal Lago DT, Bortolami R, Furness JB. Extrinsic and intrinsic sources of calcitonin gene-related peptide immunoreactivity in the lamb ileum: a morphometric and neurochemical investigation. Cell Tissue Res. 2006;323:183–196. [PubMed]
  • Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, Matsukura S, Kangawa K, Nakazato M. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000;141:4255–4261. [PubMed]
  • Date Y, Murakami N, Toshinai K, Matsukura S, Niijima A, Matsuo H, Kangawa K, Nakazato M. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology. 2002;123:1120–1128. [PubMed]
  • Djouhri L, Fang X, Okuse K, Wood JN, Berry CM, Lawson SN. The TTX-resistant sodium channel Nav1.8 (SNS/PN3): expression and correlation with membrane properties in rat nociceptive primary afferent neurons. J Physiol. 2003;550:739–752. [PubMed]
  • Drel VR, Mashtalir N, Ilnytska O, Shin J, Li F, Lyzogubov VV, Obrosova IG. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity. Diabetes. 2006;55:3335–3343. [PubMed]
  • Drucker DJ. Minireview: the glucagon-like peptides. Endocrinology. 2001;142:521–527. [PubMed]
  • Edfalk S, Steneberg P, Edlund H. Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion. Diabetes. 2008;57:2280–2287. [PMC free article] [PubMed]
  • Esni F, Taljedal IB, Perl AK, Cremer H, Christofori G, Semb H. Neural cell adhesion molecule (N-CAM) is required for cell type segregation and normal ultrastructure in pancreatic islets. J Cell Biol. 1999;144:325–337. [PMC free article] [PubMed]
  • Fox EA. A genetic approach for investigating vagal sensory roles in regulation of gastrointestinal function and food intake. Auton Neurosci. 2006;126–127:9–29. [PubMed]
  • Fox EA, Phillips RJ, Martinson FA, Baronowsky EA, Powley TL. Vagal afferent innervation of smooth muscle in the stomach and duodenum of the mouse: morphology and topography. J Comp Neurol. 2000;428:558–576. [PubMed]
  • Fujitani Y, Fujitani S, Boyer DF, Gannon M, Kawaguchi Y, Ray M, Shiota M, Stein RW, Magnuson MA, Wright CV. Targeted deletion of a cis-regulatory region reveals differential gene dosage requirements for Pdx1 in foregut organ differentiation and pancreas formation. Genes Dev. 2006;20:253–266. [PubMed]
  • Gautron L, Lee C, Funahashi H, Friedman J, Lee S, Elmquist J. Melanocortin-4 receptor expression in a vago-vagal circuitry involved in postprandial functions. J Comp Neurol. 2010;518:6–24. [PMC free article] [PubMed]
  • Gibbs J, Falasco JD, McHugh PR. Cholecystokinin-decreased food intake in rhesus monkeys. Am J Physiol. 1976;230:15–18. [PubMed]
  • Green T, Dockray GJ. Calcitonin gene-related peptide and substance P in afferents to the upper gastrointestinal tract in the rat. Neurosci Lett. 1987;76:151–156. [PubMed]
  • Halpern MS, Egan J, Mason WS, England JM. Viral antigen in endocrine cells of the pancreatic islets and adrenal cortex of Pekin ducks infected with duck hepatitis B virus. Virus Res. 1984;1:213–223. [PubMed]
  • Hancock AS, Du A, Liu J, Miller M, May CL. Glucagon deficiency reduces hepatic glucose production and improves glucose tolerance in adult mice. Mol Endocrinol. 2010;24:1605–1614. [PubMed]
  • Heiser PW, Lau J, Taketo MM, Herrera PL, Hebrok M. Stabilization of beta-catenin impacts pancreas growth. Development. 2006;133:2023–2032. [PubMed]
  • Huda MS, Mani H, Dovey T, Halford JC, Boyland E, Daousi C, Wilding JP, Pinkney J. Ghrelin inhibits autonomic function in healthy controls, but has no effect on obese and vagotomized subjects. Clin Endocrinol. 2010;73:678–685. [PubMed]
  • Iggo A. Gastric mucosal chemoreceptors with vagal afferent fibres in the cat. Q J Exp Physiol Cogn Med Sci. 1957;42:398–409. [PubMed]
  • Kosaras B, Jakubowski M, Kainz V, Burstein R. Sensory innervation of the calvarial bones of the mouse. J Comp Neurol. 2009;515:331–348. [PMC free article] [PubMed]
  • Kraus T, Neuhuber WL, Raab M. Distribution of vesicular glutamate transporter 1 (VGLUT1) in the mouse esophagus. Cell Tissue Res. 2007;329:205–219. [PubMed]
  • Laird JM, Souslova V, Wood JN, Cervero F. Deficits in visceral pain and referred hyperalgesia in Nav1.8 (SNS/PN3)-null mice. J Neurosci. 2002;22:8352–8356. [PubMed]
  • Lam CK, Chari M, Su BB, Cheung GW, Kokorovic A, Yang CS, Wang PY, Lai TY, Lam TK. Activation of N-methyl-D-aspartate (NMDA) receptors in the dorsal vagal complex lowers glucose production. J Biol Chem. 2010;285:21913–21921. [PubMed]
  • le Roux CW, Neary NM, Halsey TJ, Small CJ, Martinez-Isla AM, Ghatei MA, Theodorou NA, Bloom SR. Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J Clin Endocrinol Metab. 2005;90:4521–4524. [PubMed]
  • Liddle RA. Regulation of cholecystokinin secretion by intraluminal releasing factors. Am J Physiol. 1995;269:G319–G327. [PubMed]
  • Lindsay TH, Halvorson KG, Peters CM, Ghilardi JR, Kuskowski MA, Wong GY, Mantyh PW. A quantitative analysis of the sensory and sympathetic innervation of the mouse pancreas. Neuroscience. 2006;137:1417–1426. [PubMed]
  • Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, Ng LL, Palmiter RD, Hawrylycz MJ, Jones AR, Lein ES, Zeng H. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci. 2010;13:133–140. [PMC free article] [PubMed]
  • Matsumoto S, Yoshida S, Ikeda M, Tanimoto T, Saiki C, Takeda M, Shima Y, Ohta H. Effect of 8-bromo-cAMP on the tetrodotoxin-resistant sodium (Nav1.8) current in small-diameter nodose ganglion neurons. Neuro-pharmacology. 2007;52:904–924. [PubMed]
  • Mawe GM. Nerves and hormones interact to control gallbladder function. News Physiol Sci. 1998;13:84–90. [PubMed]
  • Mitsui R. Characterisation of calcitonin gene-related peptide-immunoreactive neurons in the myenteric plexus of rat colon. Cell Tissue Res. 2009;337:37–43. [PubMed]
  • Moran TH, Sawyer TK, Seeb DH, Ameglio PJ, Lombard MA, McHugh PR. Potent and sustained satiety actions of a cholecystokinin octapeptide analogue. Am J Clin Nutr. 1992;55(Suppl 1):286S–290S. [PubMed]
  • Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L. A global double-fluorescent Cre reporter mouse. Genesis. 2007;45:593–605. [PubMed]
  • Nakagawa A, Satake H, Nakabayashi H, Nishizawa M, Furuya K, Nakano S, Kigoshi T, Nakayama K, Uchida K. Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells. Auton Neurosci. 2004;110:36–43. [PubMed]
  • Nikoulina SE, Andon NL, McCowen KM, Hendricks MD, Lowe C, Taylor SW. A primary colonic crypt model enriched in enteroendocrine cells facilitates a peptidomic survey of regulated hormone secretion. Mol Cell Proteomics. 2010;9:728–741. [PubMed]
  • Obrosova IG, Ilnytska O, Lyzogubov VV, Pavlov IA, Mashtalir N, Nadler JL, Drel VR. High-fat diet induced neuropathy of pre-diabetes and obesity: effects of “healthy” diet and aldose reductase inhibition. Diabetes. 2007;56:2598–2608. [PubMed]
  • Page AJ, O'Donnell TA, Cooper NJ, Young RL, Blackshaw LA. Nitric oxide as an endogenous peripheral modulator of visceral sensory neuronal function. J Neurosci. 2009;29:7246–7255. [PubMed]
  • Patterson LM, Zheng H, Berthoud HR. Vagal afferents innervating the gastrointestinal tract and CCKA-receptor immunoreactivity. Anat Rec. 2002;266:10–20. [PubMed]
  • Phillips RJ, Powley TL. Tension and stretch receptors in gastrointestinal smooth muscle: re-evaluating vagal mechanoreceptor electrophysiology. Brain Res Brain Res Rev. 2000;34:1–26. [PubMed]
  • Phillips RJ, Powley TL. Plasticity of vagal afferents at the site of an incision in the wall of the stomach. Auton Neurosci. 2005;123:44–53. [PubMed]
  • Phillips RJ, Powley TL. Innervation of the gastrointestinal tract: patterns of aging. Auton Neurosci. 2007;136:1–19. [PMC free article] [PubMed]
  • Pocai A, Obici S, Schwartz GJ, Rossetti L. A brain-liver circuit regulates glucose homeostasis. Cell Metab. 2005;1:53–61. [PubMed]
  • Powley TL, Chi MM, Baronowsky EA, Phillips RJ. Gastrointestinal tract innervation of the mouse: afferent regeneration and meal patterning after vagotomy. Am J Physiol Regul Integr Comp Physiol. 2005;289:R563–R574. [PubMed]
  • Powley TL, Spaulding RA, Haglof SA. Vagal afferent innervation of the proximal gastrointestinal tract mucosa: chemoreceptor and mechanoreceptor architecture. J Comp Neurol. 2011;519:644–660. [PubMed]
  • Prechtl JC, Powley TL. The fiber composition of the abdominal vagus of the rat. Anat Embryol. 1990;181:101–115. [PubMed]
  • Raybould HE. Gut chemosensing: interactions between gut endocrine cells and visceral afferents. Auton Neurosci. 2010;153:41–46. [PMC free article] [PubMed]
  • Rinaman L, Schwartz G. Anterograde transneuronal viral tracing of central viscerosensory pathways in rats. J Neurosci. 2004;24:2782–2786. [PubMed]
  • Roth KA, Hertz JM, Gordon JI. Mapping enteroendocrine cell populations in transgenic mice reveals an unexpected degree of complexity in cellular differentiation within the gastrointestinal tract. J Cell Biol. 1990;110:1791–1801. [PMC free article] [PubMed]
  • Rush AM, Dib-Hajj SD, Liu S, Cummins TR, Black JA, Waxman SG. A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons. Proc Natl Acad Sci U S A. 2006;103:8245–8250. [PubMed]
  • Sakata I, Yamazaki M, Inoue K, Hayashi Y, Kangawa K, Sakai T. Growth hormone secretagogue receptor expression in the cells of the stomach-projected afferent nerve in the rat nodose ganglion. Neurosci Lett. 2003;342:183–186. [PubMed]
  • Sakata I, Nakano Y, Osborne-Lawrence S, Rovinsky SA, Lee CE, Perello M, Anderson JG, Coppari R, Xiao G, Lowell BB, Elmquist JK, Zigman JM. Characterization of a novel ghrelin cell reporter mouse. Regul Pept. 2009a;155:91–98. [PMC free article] [PubMed]
  • Sakata I, Yang J, Lee CE, Osborne-Lawrence S, Rovinsky SA, Elmquist JK, Zigman JM. Colocalization of ghrelin O-acyltransferase and ghrelin in gastric mucosal cells. Am J Physiol Endocrinol Metab. 2009b;297:E134–E141. [PubMed]
  • Stirling LC, Forlani G, Baker MD, Wood JN, Matthews EA, Dickenson AH, Nassar MA. Nociceptor-specific gene deletion using heterozygous NaV1.8-Cre recombinase mice. Pain. 2005;113:27–36. [PubMed]
  • Strickland IT, Martindale JC, Woodhams PL, Reeve AJ, Chessell IP, McQueen DS. Changes in the expression of NaV1.7, NaV1.8 and NaV1.9 in a distinct population of dorsal root ganglia innervating the rat knee joint in a model of chronic inflammatory joint pain. Eur J Pain. 2008;12:564–572. [PubMed]
  • Theodorakis MJ, Carlson O, Michopoulos S, Doyle ME, Juhaszova M, Petraki K, Egan JM. Human duodenal enter-oendocrine cells: source of both incretin peptides, GLP-1 and GIP. Am J Physiol Endocrinol Metab. 2006;290:E550–E559. [PubMed]
  • Vahl TP, Tauchi M, Durler TS, Elfers EE, Fernandes TM, Bitner RD, Ellis KS, Woods SC, Seeley RJ, Herman JP, D'Alessio DA. Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology. 2007;148:4965–4973. [PubMed]
  • Wang FB, Powley TL. Topographic inventories of vagal afferents in gastrointestinal muscle. J Comp Neurol. 2000;421:302–324. [PubMed]
  • Wang S, Davis BM, Zwick M, Waxman SG, Albers KM. Reduced thermal sensitivity and Nav1.8 and TRPV1 channel expression in sensory neurons of aged mice. Neurobiol Aging. 2006;27:895–903. [PMC free article] [PubMed]
  • Wang ZJ, Neuhuber WL. Intraganglionic laminar endings in the rat esophagus contain purinergic P2X2 and P2X3 receptor immunoreactivity. Anat Embryol. 2003;207:363–371. [PubMed]
  • Zimmermann K, Leffler A, Babes A, Cendan CM, Carr RW, Kobayashi J, Nau C, Wood JN, Reeh PW. Sensory neuron sodium channel Nav1.8 is essential for pain at low temperatures. Nature. 2007;447:855–858. [PubMed]